✦ LIBER ✦

1486 PUBLICATION A phase I combination study of split-dose short infusion trabectedin and doxorubicin administered every 21 days in patients with solid tumors

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I dose-escalation study of vinflun

✍ Calvo, E.; Vermorken, J. B.; Hiret, S.; Rodon, J.; Cortes, J.; Senellart, H.; de 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 242 KB

Clinical and pharmacoklnetic evaluation

✍ Thōdtmann, R.; Awada, A.; Piccart, M.; Höppener, F.; Wanders, J.; von Broen, I.- 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 387 KB

Phase I and pharmacokinetic study of Yon

✍ C. Twelves; K. Hoekman; A. Bowman; J.B. Vermorken; A. Anthoney; J. Smyth; C. van 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 279 KB

A phase I, open-label, single-arm, dose-

✍ Hong, D. S.; Kurzrock, R.; Naing, A.; Wheler, J. J.; Falchook, G. S.; Schiffman, 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 365 KB

27 ORAL Phase I dose escalation study of

✍ M. De Jonge; N. Steeghs; J. Verweij; J.W.R. Nortier; F. Eskens; J. Ouwerkerk; C. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 82 KB

496 A phase I dose-escalation study of B

✍ M. Scheulen; K. Mross; H. Richly; B. Nokay; A. Frost; D. Scharr; K.H. Lee; O. Sa 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB